» Articles » PMID: 34618688

High FODMAP Diet Causes Barrier Loss Via Lipopolysaccharide-mediated Mast Cell Activation

Overview
Journal JCI Insight
Date 2021 Oct 7
PMID 34618688
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) are carbohydrates thought to contribute to the symptoms of IBS. A diet in high in FODMAPs (HFM) induces gastrointestinal symptoms in patients with irritable bowel syndrome (IBS), and a diet low in FODMAPs (LFM) improves symptoms in up to 60% of patients with IBS. However, the mechanism by which FODMAPs affect IBS symptoms is unclear. We showed that mice fed on a HFM diet have mast cell activation and colonic barrier loss. Using mast cell-deficient mice with and without mast cell reconstitution, we showed that HFM-mediated colonic barrier loss is dependent on TLR4-dependent mast cell activation. In in vitro studies, we demonstrated that IBS fecal supernatant stimulates mast cells significantly more compared with fecal supernatant from healthy controls. This effect of IBS fecal supernatant on mast cell stimulation is ameliorated in the absence of the TLR4 receptor and after a LFM diet. We found that a LFM diet improves colonic barrier function and reduces mast cell activation while decreasing fecal LPS levels. Our findings indicate that a HFM diet causes mast cell activation via LPS, which in turn leads to colonic barrier loss, and a LFM diet reverses these pathophysiologic mucosal changes.

Citing Articles

Toll-like receptor 4 plays a vital role in irritable bowel syndrome: a scoping review.

Wan X, Wang L, Wang Z, Wan C Front Immunol. 2025; 15:1490653.

PMID: 39749341 PMC: 11693509. DOI: 10.3389/fimmu.2024.1490653.


Dietary and Nutritional Interventions for the Management of Endometriosis.

Abulughod N, Valakas S, El-Assaad F Nutrients. 2024; 16(23).

PMID: 39683382 PMC: 11643425. DOI: 10.3390/nu16233988.


Safety and Tolerability of Microbial Inulinase Supplementation in Healthy Adults: A Randomized, Placebo-Controlled Trial.

Garvey S, LeMoire A, Wang J, Lin L, Sharif B, Bier A Gastro Hep Adv. 2024; 3(7):920-930.

PMID: 39318719 PMC: 11419904. DOI: 10.1016/j.gastha.2024.05.013.


Innovative concepts in diet therapies in disorders of gut-brain interaction.

So D, Tuck C JGH Open. 2024; 8(7):e70001.

PMID: 39027160 PMC: 11255864. DOI: 10.1002/jgh3.70001.


HucMSC-Ex alleviates DSS-induced colitis in mice by decreasing mast cell activation via the IL-33/ST2 axis.

Wei Z, Tang X, Yi C, Ocansey D, Mao F, Mao Z Am J Transl Res. 2024; 16(6):2727-2744.

PMID: 39006299 PMC: 11236658. DOI: 10.62347/EXZE5413.


References
1.
Rijnierse A, Koster A, Nijkamp F, Kraneveld A . Critical role for mast cells in the pathogenesis of 2,4-dinitrobenzene-induced murine colonic hypersensitivity reaction. J Immunol. 2006; 176(7):4375-84. DOI: 10.4049/jimmunol.176.7.4375. View

2.
Vivinus-Nebot M, Dainese R, Anty R, Saint-Paul M, Nano J, Gonthier N . Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells. Am J Gastroenterol. 2011; 107(1):75-81. DOI: 10.1038/ajg.2011.315. View

3.
Chen B, Du L, He H, Kim J, Zhao Y, Zhang Y . Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model. World J Gastroenterol. 2018; 23(47):8321-8333. PMC: 5743503. DOI: 10.3748/wjg.v23.i47.8321. View

4.
Dainese R, Galliani E, De Lazzari F, Di Leo V, Naccarato R . Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol. 1999; 94(7):1892-7. DOI: 10.1111/j.1572-0241.1999.01226.x. View

5.
Eswaran S, Chey W, Han-Markey T, Ball S, Jackson K . A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D. Am J Gastroenterol. 2016; 111(12):1824-1832. DOI: 10.1038/ajg.2016.434. View